HARBORNE MEDICAL PRACTICE — All Prescriptions & Medications — Page 7
Practice Code: M85058 | BIRMINGHAM, B17 0HG
Showing results 301-350 of 650
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Sennosides | 69 | 19.0K | £366 | +123.4% ▲ |
| Ticagrelor | 68 | 8,008 | £7.8K | -20.0% ▼ |
| Azithromycin | 68 | 2,268 | £841 | -46.4% ▼ |
| Anastrozole | 68 | 3,416 | £129 | -25.3% ▼ |
| Adapalene and benzoyl peroxide | 68 | 3,615 | £1.6K | +27.3% ▲ |
| Metronidazole | 68 | 2,895 | £1.1K | +80.9% ▲ |
| Umeclidinium bromide | 67 | 102 | £2.7K | +8.7% ▲ |
| 67 | 7,350 | £14.0K | +37.5% ▲ | |
| 67 | 7,300 | £1.8K | +159.8% ▲ | |
| Eplerenone | 66 | 4,032 | £494 | -75.1% ▼ |
| RtS 1.4-1.5kcal/ml energy & higher protein liquid (0913141) | 66 | 3,636 | £8.4K | +580.7% ▲ |
| 66 | 1,260 | £1.3K | +101.0% ▲ | |
| Benzydamine hydrochloride | 64 | 17.7K | £326 | -17.3% ▼ |
| Temazepam | 63 | 1,190 | £1.0K | +10.1% ▲ |
| Levonorgestrel | 63 | 63 | £4.9K | +66.9% ▲ |
| Celecoxib | 61 | 3,804 | £223 | -7.6% ▼ |
| Fenofibrate | 60 | 3,564 | £421 | -38.0% ▼ |
| Etonogestrel | 60 | 60 | £4.8K | +107.6% ▲ |
| 60 | 60 | £9.2K | +68.0% ▲ | |
| Hydroxyzine hydrochloride | 59 | 3,276 | £105 | +10.8% ▲ |
| Diclofenac sodium | 59 | 4,259 | £710 | +16.2% ▲ |
| Amisulpride | 58 | 3,652 | £1.6K | -17.5% ▼ |
| Powder OTC or discontinued soup (0913311) | 58 | 2,727 | £2.8K | +544.8% ▲ |
| Bimatoprost | 58 | 1,653 | £751 | -61.0% ▼ |
| Prednisolone | 57 | 1,382 | £152 | -20.8% ▼ |
| Zolmitriptan | 57 | 732 | £2.5K | -12.2% ▼ |
| Insulin degludec | 57 | 336 | £3.3K | -48.1% ▼ |
| Alogliptin | 57 | 2,044 | £1.8K | -77.5% ▼ |
| Amiodarone hydrochloride | 56 | 2,100 | £114 | -13.2% ▼ |
| Vortioxetine | 56 | 2,184 | £2.1K | -19.3% ▼ |
| Sodium bicarbonate | 56 | 8,628 | £388 | -39.4% ▼ |
| Alfuzosin hydrochloride | 55 | 3,700 | £1.2K | -23.1% ▼ |
| 55 | 560 | £1.8K | +79.0% ▲ | |
| 55 | 506 | £1.1K | +127.5% ▲ | |
| Olmesartan medoxomil | 53 | 2,576 | £100 | -23.1% ▼ |
| Ipratropium bromide | 53 | 2,339 | £775 | +84.4% ▲ |
| Biphasic insulin lispro | 53 | 525 | £3.2K | +23.4% ▲ |
| Adapalene | 53 | 3,330 | £1.2K | +142.1% ▲ |
| 53 | 5,065 | £76 | +213.7% ▲ | |
| Pizotifen malate | 51 | 5,040 | £203 | -38.1% ▼ |
| Cenobamate | 51 | 1,932 | £10.4K | +110.5% ▲ |
| Dutasteride | 51 | 2,622 | £151 | -0.7% vs avg |
| Timolol and bimatoprost | 51 | 1,044 | £1.1K | -66.4% ▼ |
| Chlorhexidine gluconate | 51 | 29.0K | £503 | +72.7% ▲ |
| 51 | 51 | £259 | -0.6% vs avg | |
| Flecainide acetate | 50 | 5,160 | £180 | -36.0% ▼ |
| Theophylline | 50 | 3,360 | £1.7K | -40.2% ▼ |
| 50 | 579 | £1.9K | +27.1% ▲ | |
| Trospium chloride | 49 | 3,344 | £688 | -4.0% ▼ |
| Light liquid paraffin | 49 | 28.9K | £550 | +43.9% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.